Notable Labs Ltd. (NASDAQ: NTBL)
$0.75
+0.0200 ( +2.74% ) 16.1K
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.
Market Data
Open
$0.75
Previous close
$0.73
Volume
16.1K
Market cap
$7.11M
Day range
$0.72 - $0.79
52 week range
$0.51 - $5.27
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Apr 12, 2024 |
10-k | Annual reports | 91 | Apr 11, 2024 |
8-k | 8K-related | 15 | Apr 09, 2024 |
8-k | 8K-related | 15 | Apr 08, 2024 |
nt | Quarterly Reports | 1 | Apr 01, 2024 |
8-k | 8K-related | 13 | Mar 25, 2024 |
8-k | 8K-related | 14 | Mar 22, 2024 |
8-k | 8K-related | 16 | Feb 22, 2024 |
def | Proxies and info statements | 6 | Feb 16, 2024 |
pre | Proxies and info statements | 4 | Feb 05, 2024 |